105
Views
0
CrossRef citations to date
0
Altmetric
Research

Health-related quality of life and willingness to pay measurement among patients on warfarin in Thailand

ORCID Icon, ORCID Icon, , , & ORCID Icon
Article: 130 | Received 11 Aug 2023, Accepted 09 Oct 2023, Published online: 11 Mar 2024

References

  • Ferrans CE, Zerwic JJ, Wilbur JE, Larson JLConceptual model of health-related quality of lifeJ Nurs Scholarsh200537336342 10.1111/j.1547-5069.2005.00058.x 16396406
  • Saleem F, Hassali MA, Shafie AAA cross-sectional assessment of health-related quality of life (HRQoL) among hypertensive patients in PakistanHealth Expect201417388395 10.1111/j.1369-7625.2012.00765.x 22390260
  • Bredow T, Peterson S, Sandau KPeterson SHealth-related quality of lifeMiddle-range theory: application to nursing research2008PhiladelphiaLippincott Williams & Wilkins273289
  • Iqbal MS, Kassab YW, Al-Saikhan FI, Almalki ZS, Haseeb A, Iqbal MZ, Ali MAssessing quality of life using WHOQOL-BREF: a cross-sectional insight among patients on warfarin in MalaysiaSaudi Pharm J202028936942 10.1016/j.jsps.2020.06.014 32792838 7414056
  • Coons SJ, Rao S, Keininger DL, Hays RDA comparative review of generic quality-of-life instrumentsPharmacoeconomics2000171335 1:STN:280:DC%2BD3M%2Fgt1KitQ%3D%3D 10.2165/00019053-200017010-00002 10747763
  • Saffari M, Lin C-Y, O’Garo K, Koenig HG, Sanaeinasab H, Pakpour AHPsychometric properties of Persian diabetes-mellitus specific quality of life (DMQoL) questionnaire in a population-based sample of IraniansInt J Diabetes Dev Ctries201939218227 10.1007/s13410-018-0648-8
  • Peters M, Crocker HMaggino FCondition-specific measureEncyclopedia of quality of life and well-being research2020ChamSpringer International Publishing13
  • Haitjema S, de Borst G-J, de Vries J-P, Moll F, Pasterkamp G, den Ruijter HHealth-related quality of life is poor but does not vary with cardiovascular disease burden among patients operated for severe atherosclerotic diseaseIJC Heart Vessels201445358 10.1016/j.ijchv.2014.07.001
  • Number and death rate of non-communicable Disease in Thailand 2017–2021. Division of Non Communicable Disease in Thailand. 2021. http://www.thaincd.com/2016/mission/documents-detail.php?id=14480&tid=32&gid=1-020. Accessed 18 July 2023.
  • Radaideh KM, Matalqah LMHealth-related quality of life among atrial fibrillation patients using warfarin therapyEpidemiol Biostat Public Health2018151
  • Yusuf S, Reddy S, Ôunpuu S, Anand SGlobal burden of cardiovascular diseases: part II: variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategiesCirculation200110428552864 1:STN:280:DC%2BD3MnoslSntA%3D%3D 10.1161/hc4701.099488 11733407
  • Dipiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM. Pharmacotherapy: a pathophysiologic approach, ed. Connecticut: Appleton and Lange. 2014;4:141–2.
  • Chu VL, Maltz HCCohen HWarfarinCasebook in clinical pharmacokinetics and drug dosing2015New YorkMcGraw-Hill Education
  • Iqbal MS, Muthanna FM, Kassab YW, Hassali MA, Al-Saikhan FI, Iqbal MZ, Haseeb A, Ahmed M, Khan SU, Naqvi AA, Islam MA, Ali MDeterminants of health-related quality of life among warfarin patients in PakistanPLoS ONE2020156 10.1371/journal.pone.0234734
  • Samsa G, Matchar DB, Dolor RJ, Wiklund I, Hedner E, Wygant G, Hauch O, Marple CB, Edwards RA new instrument for measuring anticoagulation-related quality of life: development and preliminary validationHealth Qual Life Outcomes2004222 10.1186/1477-7525-2-22 15132746 420491
  • Gafou A, Maragos K, Bellia M, Digenopoulou-Andrioti E, Theodosiadis GInstruments for measuring anticoagulation-related quality of life: modification, and preliminary validationHaema200710129141
  • Quality of life indicators of the World Health Organization Thai version (WHOQOL-bref-Thai): Department of Mental Health. 2022. https://www.dmh.go.th/test/whoqol/. Accessed 14 Febuary 2022.
  • O’Brien B, Gafni AWhen do the “dollars” make sense? Toward a conceptual framework for contingent valuation studies in health careMed Decis Making199616288299 10.1177/0272989X9601600314 8818128
  • Olsen JA, Smith RDTheory versus practice: a review of ‘willingness-to-pay’ in health and health careHealth Econ2001103952 1:STN:280:DC%2BD3M3ht1Omtg%3D%3D 10.1002/1099-1050(200101)10:1<39::AID-HEC563>3.0.CO;2-E 11180568
  • Bala MV, Mauskopf JA, Wood LLWillingness to pay as a measure of health benefitsPharmacoeconomics199915918 1:STN:280:DyaK1M7jvVSmtA%3D%3D 10.2165/00019053-199915010-00002 10345161
  • Ng SS, Nathisuwan S, Phrommintikul A, Chaiyakunapruk NCost-effectiveness of warfarin care bundles and novel oral anticoagulants for stroke prevention in patients with atrial fibrillation in ThailandThromb Res20201856371 1:CAS:528:DC%2BC1MXit1amu7nE 10.1016/j.thromres.2019.11.012 31770689
  • Mahatnirundkul SComparison of the WHOQOL-100 and the WHOQOL-BREF (26 items)J Ment Health Thai19985415
  • Taboonpong S, Suttharangsee W, Chailangka PEvaluating psychometric properties of WHO quality of life questionnaire in Thai elderlyJ Gerontol Geriatric Med20012612
  • Phungrassami T, Katikarn R, Watanaarepornchai S, Sangtawan DQuality of life assessment in radiotherapy patients by WHOQOL-BREF-THAI: a feasibility studyJ Med Assoc Thai20048714591465 15822541
  • Sakthong P, Schommer JC, Gross CR, Sakulbumrungsil R, Prasithsirikul WPsychometric properties of WHOQOL-BREF-THAI in patients with HIV/AIDSJ Med Assoc Thai20079024492460 18181334
  • Pattanaphesaj J, Thavorncharoensap M, Ramos-Goñi JM, Tongsiri S, Ingsrisawang L, Teerawattananon YThe EQ-5D-5L valuation study in ThailandExpert Rev Pharmacoecon Outcomes Res201818551558 10.1080/14737167.2018.1494574 29958008
  • Oemar M, Janssen B. EQ-5D-5L User Guide Basic information on how to use the EQ-5D-5L instrument. EuroQol group 2013.
  • Chevadisaikul T, Kapol NWillingness to pay for hospital pharmacist’s dispensing services: a case study of Mettapracharak (Wat Raikhing) hospital2019BangkokSilpakorn University
  • Thavorncharoensap M, Teerawattananon Y, Natanant S, Kulpeng W, Yothasamut J, Werayingyong PEstimating the willingness to pay for a quality-adjusted life year in Thailand: does the context of health gain matter?Clinicoecon Outcomes Res201352936 10.2147/CEOR.S38062 23345984 3548562
  • Kananurak PWillingness to pay for voluntary health insurance after retirement in ThailandNIDA Dev J201454117157
  • Hammouri HM, Sabo RT, Alsaadawi R, Kheirallah KAHandling skewed data: a comparison of two popular methodsAppl Sci2020106247 1:CAS:528:DC%2BB3cXitFartLbL 10.3390/app10186247
  • Chalet F-X, Bujaroska T, Germeni E, Ghandri N, Maddalena ET, Modi K, Olopoenia A, Thompson J, Togninalli M, Briggs AHMapping the Insomnia Severity index instrument to EQ-5D health state utilities: a United Kingdom perspectivePharmacoecon Open20237149161 10.1007/s41669-023-00388-0 36703022 9928998
  • Kangwanrattanakul KNormative profile of the EQ-5D-5L dimensions, EQ-5D-5L index and EQ-VAS scores for the general Thai populationQual Life Res20233224892502 10.1007/s11136-023-03420-2 37060516
  • Kangwanrattanakul KA comparison of measurement properties between UK SF-6D and English EQ-5D-5L and Thai EQ-5D-5L value sets in general Thai populationExpert Rev Pharmacoecon Outcomes Res202121765774 10.1080/14737167.2021.1829479 32981380
  • Sakthong P, Sonsa-Ardjit N, Sukarnjanaset P, Munpan WPsychometric properties of the EQ-5D-5L in Thai patients with chronic diseasesQual Life Res20152430153022 10.1007/s11136-015-1038-z 26048348
  • Bleichrodt H, Crainich D, Eeckhoudt LComorbidities and the willingness to pay for health improvementsJ Public Econ20038723992406 10.1016/S0047-2727(02)00047-6
  • Bhatnagar P, Wickramasinghe K, Williams J, Rayner M, Townsend NThe epidemiology of cardiovascular disease in the UK 2014Heart201510111821189 1:CAS:528:DC%2BC28XnvVKks7k%3D 10.1136/heartjnl-2015-307516 26041770
  • Sullivan T, Turner RM, Derrett S, Hansen PNew Zealand population norms for the EQ-5D-5L constructed from the personal value sets of participants in a national surveyValue Health20212413081318 10.1016/j.jval.2021.04.1280 34452711
  • Kangwanrattanakul K, Auamnoy TPsychometric testing of the health-related quality of life measurement, SF-36v2, in the general population of ThailandExpert Rev Pharmacoecon Outcomes Res201919313320 10.1080/14737167.2019.1530595 30266079